The moment we’ve all been waiting for! Concord Biotech has made a grand entrance into the stock market with a 22% premium over its IPO issue price at Rs 900! Investors are clearly confident in the company’s potential for growth and success. Let’s raise a glass to Concord Biotech’s triumph and wish them all the best for their future endeavors!
Concord Biotech’s debut on the stock exchanges. Concord Biotech’s stock made a strong debut by opening at Rs 900 apiece, which represented a 22 percent premium over the initial public offering (IPO) issue price. This means that the stock price at debut was 22 percent higher than the price at which the company initially offered […]
Read More
UtkarshSmallFinanceBank has made a remarkable debut on D-Street, listing at a whopping 60% premium! We are thrilled to witness such a strong start and look forward to serving our customers with utmost dedication and commitment.
Utkarsh Small Finance Bank’s entry on the stock exchange has been highly impressive, as the stock debuted with a significant premium over its IPO price. The company’s IPO price was set at Rs 25, but when the stock was listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE), it opened at […]
Read More